For instance, it is well established that decreased Aβ-42 and elevated total Tau and phospho-Tau in CSF are considered specific markers of AD [37,38], and that these biomarkers can predict cognitive decline over time [39]. The gene discussed is MAPT; the disease is Alzheimer disease.